• About
    ▼
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    ▼
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Publications
  • Pipeline
    ▼
    • Overview
    • Ulviprubart
    • IBM
    • T-LGLL
    • T and NK Cell Lymphomas
    • Additional Indications
  • Clinical Trials
  • News
  • Careers
  • Contact
Careers

Careers

Abcuro

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Publications
  • Pipeline
    • Overview
    • Ulviprubart
    • IBM
    • T-LGLL
    • T and NK Cell Lymphomas
    • Additional Indications
  • Clinical Trials
  • News
  • Careers
  • Contact

Careers

Working at Abcuro

At Abcuro, we’re dedicated to developing breakthrough therapeutics for high unmet needs in autoimmune disease and cancer. To achieve this important goal, we have assembled an experienced and dedicated team that shares a passion for bringing meaningful therapeutic advances to patients.

Our team is deeply curious, analytical, and driven to make a difference for patients. If you share these qualities and believe our mission, we’d love to hear from you.

OPEN POSITIONS

Thanks for checking us out. Unfortunately, we don’t have any openings at this time but keep an eye out for future opportunities.

Privacy Site Credits Terms of Use

© 2025 Abcuro

NOTE

Beware of individuals posing as Abcuro recruiters online. These scammers, posing as employees of Abcuro, may offer fake job opportunities and request sensitive personal or financial information.

Abcuro will never ask for personal or sensitive information, require you to purchase equipment or make payments, or request any financial commitments of any kind as part of our search process.

All legitimate job postings are found on our careers site. Emails from senders claiming to work for Abcuro, without an @abcuro.com address, are fraudulent.